Literature DB >> 26991672

Stable Blue Phosphorescence Iridium(III) Cyclometalated Complexes Prompted by Intramolecular Hydrogen Bond in Ancillary Ligand.

Seungjun Yi1, Jin-Hyoung Kim1, Yang-Jin Cho1, Jiwon Lee2, Tae-Sup Choi1, Dae Won Cho1, Chyongjin Pac1, Won-Sik Han2, Ho-Jin Son1, Sang Ook Kang1.   

Abstract

Improvement of the stability of blue phosphorescent dopant material is one of the key factors for real application of organic light-emitting diodes (OLEDs). In this study, we found that the intramolecular hydrogen bonding in an ancillary ligand from a heteroleptic Ir(III) complex can play an important role in the stability of blue phosphorescence. To rationalize the role of intramolecular hydrogen bonding, a series of Ir(III) complexes is designed and prepared: Ir(dfppy)2(pic-OH) (1a), Ir(dfppy)2(pic-OMe) (1b), Ir(ppy)2(pic-OH) (2a), and Ir(ppy)2(pic-OMe) (2b). The emission lifetime of Ir(dfppy)2(pic-OH) (1a) (τem = 3.19 μs) in dichloromethane solution was found to be significantly longer than that of Ir(dfppy)2(pic-OMe) (1b) (τem = 0.94 μs), because of a substantial difference in the nonradiative decay rate (knr = 0.28 × 10(5) s(-1) for (1a) vs 2.99 × 10(5) s(-1) for (1b)). These results were attributed to the intramolecular OH···O═C hydrogen bond of the 3-hydroxy-picolinato ligand. Finally, device lifetime was significantly improved when 1a was used as the dopant compared to FIrpic, a well-known blue dopant. Device III (1a as dopant) achieved an operational lifetime of 34.3 h for an initial luminance of 400 nits compared to that of device IV (FIrpic as dopant), a value of 20.1 h, indicating that the intramolecular hydrogen bond in ancillary ligand is playing an important role in device stability.

Entities:  

Year:  2016        PMID: 26991672     DOI: 10.1021/acs.inorgchem.5b02511

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  6 in total

1.  Intramolecular Hydrogen Bond Expectations in Medicinal Chemistry.

Authors:  Fabrizio Giordanetto; Christian Tyrchan; Johan Ulander
Journal:  ACS Med Chem Lett       Date:  2017-01-18       Impact factor: 4.345

2.  DFT/TDDFT computational study of the structural, electronic and optical properties of rhodium (III) and iridium (III) complexes based on tris-picolinate bidentate ligands.

Authors:  Houari Brahim; Boumediene Haddad; Sefia Brahim; Abdelkrim Guendouzi
Journal:  J Mol Model       Date:  2017-11-17       Impact factor: 1.810

3.  Evidence for Triplet Sensitization in the Visible-Light-Induced [2+2] Photocycloaddition of Eniminium Ions.

Authors:  Fabian M Hörmann; Tim S Chung; Elsa Rodriguez; Matthias Jakob; Thorsten Bach
Journal:  Angew Chem Int Ed Engl       Date:  2017-12-13       Impact factor: 15.336

4.  Mitochondria-targeted spin-labelled luminescent iridium anticancer complexes.

Authors:  V Venkatesh; Raul Berrocal-Martin; Christopher J Wedge; Isolda Romero-Canelón; Carlos Sanchez-Cano; Ji-Inn Song; James P C Coverdale; Pingyu Zhang; Guy J Clarkson; Abraha Habtemariam; Steven W Magennis; Robert J Deeth; Peter J Sadler
Journal:  Chem Sci       Date:  2017-10-20       Impact factor: 9.825

5.  Tuning the Geometrical Structures and Optical Properties of Blue-Emitting Iridium(III) Complexes through Dimethylamine Substitutions: A Theoretical Study.

Authors:  Xue-Feng Ren; Hong-Qu Tang; Guo-Jun Kang
Journal:  Molecules       Date:  2017-05-07       Impact factor: 4.411

6.  Cyclometalated Iridium(III) Complexes Incorporating Aromatic Phosphonate Ligands: Syntheses, Structures, and Tunable Optical Properties.

Authors:  Dai Zeng; Xiang-Ai Yuan; Jing-Cui Liu; Li Li; Lu-Ping Wang; Ming-Feng Qin; Song-Song Bao; Jing Ma; Li-Min Zheng
Journal:  ACS Omega       Date:  2019-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.